WisdomAI | $23,000,000 | (May 8, 2025)
PAQ Therapeutics | $39,000,000 | (May 8, 2025)
WONDERSKIN | $50,000,000 | (May 8, 2025)
Certified by Founder
Lodge
Rampart Bioscience
start up
United States
- Delhi, California
- 25/10/2023
- Series A
- $85,000,000
Rampart Bioscience is evolving a new class of medicines for patients with genetically driven diseases. We integrate capabilities from a variety of key scientific disciplines — including gene delivery, protein sciences and clinical translation — to leap beyond the limitations of current gene therapies.
Powered by our novel non-viral DNA delivery system, we are on a path to achieve higher standards for potency, durability, redosability and safety. Together, we are working to reshape the treatment landscape for people in dire need of better options.
- Industry Biotechnology Research
- Website https://rampartbio.com/
- LinkedIn https://www.linkedin.com/company/rampart-bioscience/about/
Gardin Agritech | $4,500,000 | (May 8, 2025)
InspeCity | $5,600,000 | (May 8, 2025)
Alice.tech | $4,200,000 | (May 8, 2025)
CodeAnt AI (YC W24) | $2,000,000 | (May 8, 2025)
Operand | $3,100,000 | (May 8, 2025)
ImmuneWalk Therapeutics | $7,000,000 | (May 8, 2025)
CueZen | $5,000,000 | (May 8, 2025)
Row Zero | $10,000,000 | (May 7, 2025)
Trilobio | $8,000,000 | (May 7, 2025)